Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alar necrosis after facial injection of hyaluronic Acid.
Burt B, Nakra T, Isaacs DK, Goldberg RA. Burt B, et al. Plast Reconstr Surg. 2010 May;125(5):199e-200e. doi: 10.1097/PRS.0b013e3181d5152e. Plast Reconstr Surg. 2010. PMID: 20440131 No abstract available.
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors.
Hughes MS, Aleppo G, Bally L, Batista AFMB, Brown SA, Faulds ER, Gonder-Frederick LA, Isaacs D, Kahkoska AR, Ortega J, Polonsky WH, Stumpf MM. Hughes MS, et al. Among authors: isaacs d. J Diabetes Sci Technol. 2024 Nov 20:19322968241296853. doi: 10.1177/19322968241296853. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39564761 Free PMC article.
Apathy and Functional Status in Early-Stage Huntington's Disease.
Gibson JS, Hay KR, Claassen DO, McDonell KE, Brown AE, Wynn A, Jiang J, Isaacs DA. Gibson JS, et al. Among authors: isaacs da. J Neuropsychiatry Clin Neurosci. 2024 Nov 19:appineuropsych20230225. doi: 10.1176/appi.neuropsych.20230225. Online ahead of print. J Neuropsychiatry Clin Neurosci. 2024. PMID: 39558706
De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D).
Rodriguez P, Breslaw N, Xiao H, Bena J, Jenkins K, Isaacs D, Zhou K, Griebeler ML, Burguera B, Pantalone KM; TRANSITION‐T2D Investigators. Rodriguez P, et al. Among authors: isaacs d. Diabetes Obes Metab. 2024 Nov 12. doi: 10.1111/dom.16057. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39532398
809 results